American Society of Hematology, Blood, 5(130), p. 643-654
DOI: 10.1182/blood-2017-03-769315
Full text: Unavailable
Key Points Xenografted ALL cells faithfully recapitulate CNS leukemia and are characterized by high expression of VEGF, mediating CNS entry of ALL cells. VEGF captured by bevacizumab in vivo specifically reduces CNS leukemia, providing a novel strategy to target CNS involvement in ALL.